The impact of hidradenitis suppurativa on work productivity and activity impairment

V K Sandhu¹, M Shah¹, V Piguet^{2

3}, A Alavi^{2

3

4}

Affiliations

¹ Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
² Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada.
³ Division of Dermatology, Women's College Hospital, Toronto, ON, Canada.
⁴ York Dermatology Center, Richmond Hill, ON, Canada.

V K Sandhu et al. Br J Dermatol. 2020 May.

. 2020 May;182(5):1288-1290.

doi: 10.1111/bjd.18695. Epub 2019 Dec 11.

V K Sandhu¹, M Shah¹, V Piguet^{2

3}, A Alavi^{2

3

4}

¹ Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
² Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada.
³ Division of Dermatology, Women's College Hospital, Toronto, ON, Canada.
⁴ York Dermatology Center, Richmond Hill, ON, Canada.

No abstract available

References

1. Matusiak Ł, Bieniek A, Szepietowski J. Hidradenitis suppurativa markedly decreases quality of life and professional activity. J Am Acad Dermatol 2010; 62:706-8.e1.
1. Machado M, Stergiopoulos V, Maes M et al. Depression and anxiety in adults with hidradenitis suppurativa. JAMA Dermatol 2019; 155:939-45.
1. Bronckers IMGJ, van Geel MJ, van de Kerkhof PCM et al. A cross-sectional study in young adults with psoriasis: potential determining factors in quality of life, life course and work productivity. J Dermatolog Treat 2019; 30:208-15.
1. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res 2002; 52:69-71.
1. Kimball AB, Yu AP, Signorovitch J et al. The effects of adalimumab treatment and psoriasis severity on self-reported work productivity and activity impairment for patients with moderate to severe psoriasis. J Am Acad Dermatol 2012; 66:e67-e76.